Press releases | WebDisclosure

Basculer en Français

10837	Companies
235306	Keywords
164227	Articles
126040	Press releases

Home
Press releases

PRESS RELEASE

published on 04/23/2026 at 07:30, 3 months 23 days ago

OSE Immunotherapeutics Announces Presentation of TEDOVA Phase 2 Topline Results of Tedopi® in Ovarian Cancer at the ASCO 2026 Meeting
OSE Immunotherapeutics announces topline results from TEDOVA Phase 2 trial of Tedopi® in Ovarian Cancer at ASCO 2026 Meeting. Presentation by lead investigator Alexandra Leary, MD, PhD

Ovarian Cancer OSE Immunotherapeutics Tedopi® TEDOVA Phase 2 ASCO 2026
PRESS RELEASE

published on 04/23/2026 at 07:00, 3 months 23 days ago

Helvetia Baloise successfully places three senior bond tranches totalling CHF 550 million
Helvetia Baloise successfully places three senior bond tranches totalling CHF 550 million on Swiss capital market. Proceeds for corporate purposes & potential refinancing. Strong investor demand

Investor Demand Swiss Capital Market Helvetia Baloise Senior Bond Tranches CHF 550 Million
PRESS RELEASE

published on 04/23/2026 at 07:00, 3 months 23 days ago

Sartorius marks positive start to 2026: Considerable sales revenue growth and resilient profit margin
Sartorius AG marks positive start to 2026 with 7.5% sales revenue growth and 29.7% profit margin. Full-year guidance confirmed. Bioprocess Solutions grows by 8.1%

Sartorius AG Full-year Guidance Profit Margin Bioprocess Solutions Sales Revenue Growth
PRESS RELEASE

published on 04/23/2026 at 07:00, 3 months 23 days ago

Sartorius Stedim Biotech reports robust first-quarter results for fiscal 2026
Sartorius Stedim Biotech reports robust first-quarter results for fiscal 2026 with sales revenue up 7.9% in constant currencies. Profitability remains strong with a margin of 30.7% and net profit of 88 million euros

Profitability Sartorius Stedim Biotech Sales Revenue First-quarter Results Fiscal 2026
PRESS RELEASE

published on 04/23/2026 at 07:00, 3 months 23 days ago

Sartorius Stedim Biotech publie de bons résultats pour le premier trimestre de l’exercice 2026
Sartorius Stedim Biotech publie de bons résultats pour le premier trimestre de l'exercice 2026, avec un chiffre d'affaires en hausse de 7,9% à taux de change constant

Chiffre D'affaires Croissance EBITDA Sartorius Stedim Biotech Résultat Trimestriel
REGULATED PRESS RELEASE

published on 04/23/2026 at 07:00, 3 months 23 days ago

bioMérieux – First-Quarter 2026 Business Review
bioMérieux reports -3.9% organic sales decline in Q1 2026 due to weaker respiratory season and geopolitical factors. Revises 2026 guidance. CEO emphasizes innovation and cost control for positive CEBIT evolution

Innovation BioMérieux Sales Decline 2026 Guidance CEBIT Evolution
REGULATED PRESS RELEASE

published on 04/23/2026 at 07:00, 3 months 23 days ago

Safran reports first quarter 2026 revenue
Safran reports strong Q1 2026 revenue growth of 18.8%, CEO expresses confidence in full-year outlook, details key division performances and currency hedging strategy

Safran Revenue Growth CEO Statement Currency Hedging Q1 2026
REGULATED PRESS RELEASE

published on 04/23/2026 at 07:00, 3 months 23 days ago

Edenred records sustained growth in Q1 and confirms its objectives for 2026 and beyond
Edenred reports +8.2% revenue growth in Q1 2026, maintains objectives for 2026. Receives 'A' rating from CDP for ESG leadership. Amplify25-28 strategic plan execution continues

Edenred Revenue Growth Q1 2026 CDP 'A' Rating Amplify25-28
REGULATED PRESS RELEASE

published on 04/23/2026 at 07:00, 3 months 23 days ago

Safran publie son chiffre d’affaires du 1er trimestre 2026
Safran publie son chiffre d'affaires du 1er trimestre 2026 avec une forte croissance. Perspectives confirmées pour l'année. Communiqué détaillé sur les activités et performances financières

Chiffre D'affaires Croissance Safran Performances Financières Trimestre 2026
REGULATED PRESS RELEASE

published on 04/23/2026 at 07:00, 3 months 23 days ago

Edenred enregistre une croissance soutenue au premier trimestre et confirme ses objectifs pour 2026 et au-delà
Edenred enregistre une croissance soutenue au premier trimestre 2026, confirmant ses objectifs pour 2026 et au-delà. Détails sur la croissance des secteurs et la note "A" du CDP

Edenred Croissance Objectifs Secteurs Note A

Accesswire

Published on 08/15/2026 at 00:50, 2 days 3 hours ago

Revive Therapeutics Reports Grant of Options
Published on 08/15/2026 at 00:15, 2 days 4 hours ago

Full Circle Lithium Announces Closing of Private Placement
Published on 08/14/2026 at 23:45, 2 days 5 hours ago

AI/ML Innovations Inc. Announces Proposed Private Placement
Published on 08/14/2026 at 23:25, 2 days 5 hours ago

NuRAN Wireless Closes $7.6 Million Financing
Published on 08/14/2026 at 23:00, 2 days 5 hours ago

Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call

View all ACCESSWIRE

EQS Group

Published on 08/17/2026 at 02:00, 2 hours 47 minutes ago

Sandoz announces strategic collaboration with Henlius on up to 10 biosimilars, further expanding industry-leading pipeline
Published on 08/16/2026 at 19:40, 9 hours 7 minutes ago

APIC delivers 55% EBITDA growth in the first half of 2026, reaching USD 44 million
Published on 08/16/2026 at 13:40, 15 hours 7 minutes ago

Ajax says goodbye to Godts with a classy message in Paris: THE FUTURE BELONGS TO YOUNG GODTS
Published on 08/16/2026 at 09:45, 19 hours 2 minutes ago

Ragnarok Zero: Global Set to Officially Launch on August 18
Published on 08/16/2026 at 06:15, 22 hours 32 minutes ago

GARVEE met en avant les essentiels pour la maison et le jardin à l’approche de la transition entre la fin de l’été et le début de l’automne

Les Echos

Published on 08/13/2026 at 18:00, 3 days 10 hours ago

Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€
Published on 08/11/2026 at 17:45, 5 days 11 hours ago

DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 5 days 11 hours ago

Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 6 days 10 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 6 days 10 hours ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026

View all LES ECHOS COMFI WIRE